Lottery Incentive Program for High Blood Pressure
(BETTER-BP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial encourages patients with high blood pressure, who don't take their medication regularly, to stick to their treatment by offering chances to win prizes.
Do I have to stop taking my current medications for this trial?
The trial does not specify that you need to stop taking your current medications. In fact, you need to have an active prescription for at least one antihypertensive medication to participate.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, since the study focuses on improving adherence to antihypertensive medication, it seems likely that you will continue your current medication.
What safety data exists for the Lottery Incentive Program for High Blood Pressure?
The available research does not directly address safety data for the Lottery Incentive Program for High Blood Pressure. The BETTER-BP study focuses on improving medication adherence through a lottery incentive but does not provide specific safety data. Other studies mentioned do not relate to the safety of this program.12345
Is the Lottery Incentive Program for High Blood Pressure safe for humans?
The available research does not provide specific safety data for the Lottery Incentive Program for High Blood Pressure, but it is part of a study designed to improve medication adherence using behavioral economics, which generally focuses on changing behavior rather than introducing new medications or treatments.12345
Is the Regret Lottery treatment a promising way to help people stick to their high blood pressure medication?
How is the Regret Lottery treatment for high blood pressure different from other treatments?
The Regret Lottery treatment is unique because it uses a behavioral economics approach, offering a lottery-based incentive to encourage patients to stick to their blood pressure medication schedule, which is different from traditional treatments that focus solely on medication without such incentives.12367
What data supports the idea that Lottery Incentive Program for High Blood Pressure is an effective treatment?
The available research shows that the Lottery Incentive Program for High Blood Pressure, also known as BETTER-BP, was designed to improve adherence to blood pressure medication and reduce blood pressure levels. Although the specific results of this program are not detailed in the provided information, the concept of using financial incentives to improve health outcomes is supported by other studies. For example, a study on financial incentives for health screenings showed a significant increase in participation rates, with the most effective intervention leading to a 31.2 percentage point increase in screenings for conditions like hypertension. This suggests that similar incentive-based approaches, like the Lottery Incentive Program, could be effective in encouraging people to stick to their blood pressure treatment plans.23689
What data supports the effectiveness of the Lottery Incentive Program for High Blood Pressure treatment?
Research shows that financial incentives can improve medication adherence, as seen in a study where conditional financial incentives significantly increased health screening rates for conditions like hypertension. Additionally, behavioral economic strategies, like those used in the BETTER-BP trial, are promising for improving adherence to blood pressure medication.23689
Who Is on the Research Team?
John Dodson, MD
Principal Investigator
New York Langone Health
Are You a Good Fit for This Trial?
The BETTER-BP trial is for individuals with high blood pressure who have been less than 80% adherent to their antihypertensive medication. Participants must have at least one blood pressure reading of ≥140 mmHg, a hypertension diagnosis, and be on prescribed medication like thiazide diuretics or ACE inhibitors. It's not for pregnant individuals, those unable to use the study app in English/Spanish, with technology barriers due to sensory impairments, incarceration, or life expectancy under 12 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Enrollment
Baseline enrollment will occur over 36 months
Treatment
Participants receive a lottery incentive program to promote adherence to antihypertensive medication delivered via smartphone
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Control Condition
- Regret Lottery
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator